Design of Randomized, double-blind Evaluation in secondary Stroke Prevention comparing the EfficaCy and safety of the oral Thrombin inhibitor dabigatran etexilate vs. acetylsalicylic acid in patients with Embolic Stroke of Undetermined Source (RE-SPECT ESUS) - Diener, H C; Easton, J D; Granger, C B (Int J Stroke, 2015)
et al.